Editas Medicine, Inc. (EDIT)
2.75
+0.06
(+2.23%)
USD |
NASDAQ |
Sep 24, 16:00
2.80
+0.05
(+1.82%)
After-Hours: 06:35
Editas Medicine Gross Profit (Annual) : 35.24M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 35.24M |
| December 31, 2024 | 26.50M |
| December 31, 2023 | 72.06M |
| December 31, 2022 | 13.38M |
| December 31, 2021 | 20.49M |
| December 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Recursion Pharmaceuticals, Inc. | -46.27M |
| Geron Corp. | 179.14M |
| Halozyme Therapeutics, Inc. | 1.091B |
| Novavax, Inc. | 1.052B |
| AVITA Medical, Inc. | 58.82M |